BLCO | Bausch + Lomb CorporationNYSEHealthcareCommon stock golden cross and death cross projections, cross tests and history

$20.03
+$0.02 (+0.10%)

Bausch + Lomb Corporation (BLCO) is a NYSE-listed common stock that Cruxta has tracked for 50/200 crosses since 2023.

The 50 SMA has sat above the 200 on the daily since Aug 2026, with no cross projected inside the 30 bars Cruxta tracks. Price sits above the 50 and the 200 on the daily, the weekly and the 4-hour.

Timeframe summary

Daily as of 3 Nov 16:00 ET

Price
above both $20.03 vs 50 $17.46 / 200 $16.70
Projection
No cross projected
Test
No active test
Last cross
Golden cross 27 Aug 2026 ยท projected 30 bars out

Weekly as of 30 Oct 16:00 ET

Price
above both $20.00 vs 50 $16.69 / 200 $16.35
Projection
No cross projected
Test
No active test
Last cross
Golden cross week of 24 Aug 2026 ยท projected 16 bars out ยท tested 3 bars

4-hour as of 3 Nov 16:00 ET

Price
above both $20.03 vs 50 $17.58 / 200 $16.91
Projection
No cross projected
Test
No active test
Last cross
Golden cross 23 Jul 2026 bar 2 ยท projected 28 bars out ยท tested 6 bars

Cross history

15
crosses on record since 2023
8 golden7 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
27 Aug 2026Golden moderatedaily30 bars outNot tested
week of 24 Aug 2026Golden flatweekly16 bars out3 bar cross test
23 Jul 2026Golden4-hour28 bars out6 bar cross test
29 May 2026Death moderatedaily13 bars outNot tested
1 Apr 2026Death4-hour26 bars out5 bar cross test

About BLCO

ExchangeNYSE
InstrumentCommon stock
Median $ volume, 60 d$6.9M
4-hour coverageYes, since Oct 2025
History on recordSince 2023
SectorHealthcare
Cap bandmid

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.